Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296 COMPLETED

This is a retrospective and prospective multicenter observational study with the aim to evaluate the real-life use of Fostamatinib in adult patients with chronic ITP, refractory to other treatments.

Details

Lead sponsor	Gruppo Italiano Malattie EMatologiche dell'Adulto
Status	COMPLETED
Enrolment	95
Start date	Fri May 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri May 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• ITP - Immune Thrombocytopenia
• Chronic ITP
• Refractory ITP

Interventions

• Fostamatinib

Countries

Italy